Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6K Buy
905
+129
+17% +$892 ﹤0.01% 9274
2014
Q2
$5K Buy
776
+626
+417% +$4.92K ﹤0.01% 9495
2014
Q1
$1K Sell
150
-1,309
-90% -$9.66K ﹤0.01% 10193
2013
Q4
$10K Buy
1,459
+1,073
+278% +$7.69K ﹤0.01% 8965
2013
Q3
$3K Sell
386
-45
-10% -$323 ﹤0.01% 9747
2013
Q2
$3K Buy
+431
New +$3.21K ﹤0.01% 9591

Other funds holding DXR

UBS's DXR Position: Q3 2014 in Review

UBS increased its Daxor (DXR) stake by 17% in Q3 2014, buying an estimated $892 and bringing the position to 905 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9274.

UBS first reported a position in DXR in Q2 2013 and has held it in 6 quarters since. The position peaked at $10K in Q4 2013. 10 funds tracked by Wall St. Rank hold DXR as of Q3 2014.

  • UBS held 905 shares of Daxor worth $6K as of Q3 2014.
  • UBS bought 129 Daxor shares in Q3 2014, an estimated $892.
  • Daxor made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9274 holding.
  • UBS first reported a position in Daxor in Q2 2013 and has held it in 6 quarters since.
  • UBS's Daxor position peaked at $10K in Q4 2013.
  • 10 funds tracked by Wall St. Rank held Daxor as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.